NCT04838951

Brief Summary

The investigator's hypothesis is that a CADe system (ENDO-AID) would improve the adenoma detection rate in junior endoscopists.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
856

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 23, 2021

Completed
17 days until next milestone

First Posted

Study publicly available on registry

April 9, 2021

Completed
10 days until next milestone

Study Start

First participant enrolled

April 19, 2021

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 22, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

February 8, 2023

Status Verified

February 1, 2023

Enrollment Period

1.3 years

First QC Date

March 23, 2021

Last Update Submit

February 6, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • ADR

    adenoma detection rate

    During the colonoscopy

Secondary Outcomes (13)

  • ADR for adenomas of different sizes

    During the colonoscopy

  • ADR for adenomas of different colonic segments

    During the colonoscopy

  • Mean number of adenomas per colonoscopy

    During the colonoscopy

  • Advanced adenoma detection rate

    During the colonoscopy

  • Sessile serrate lesion (SSL) detection rate

    During the colonoscopy

  • +8 more secondary outcomes

Study Arms (2)

Intervention arm

EXPERIMENTAL

CADe system will be used during withdrawal phase of colonoscopy.

Device: ENDO-AID CADe

Control arm

NO INTERVENTION

Colonoscopy will be performed according to hospital protocol.

Interventions

ENDO-AID CADe will be used during the withdrawal process of the colonoscopy.

Intervention arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years old or above;
  • They require elective colonoscopy for colorectal cancer screening, polyp surveillance, or investigation of symptoms such as anemia or gastrointestinal bleeding;
  • Written informed consent obtained.

You may not qualify if:

  • Contraindication to colonoscopy (e.g. intestinal obstruction or perforation)
  • Contraindication or conditions precluding polyp resection (e.g. active gastrointestinal bleeding, significant bleeding tendency, uninterrupted anticoagulation or dual antiplatelets)
  • Scheduled staged procedure for polypectomy or biopsy
  • Previous colonic resection
  • Personal history of colorectal cancer
  • Personal history of polyposis syndrome
  • Personal history of inflammatory bowel disease
  • Advanced comorbid conditions (defined as American Society of Anesthesiologists grade 4 or above)
  • Pregnancy
  • Unable to obtain informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Prince of Wales Hospital

Shatin, New Territories, Hong Kong

Location

Related Publications (1)

  • Lau LHS, Ho JCL, Lai JCT, Ho AHY, Wu CWK, Lo VWH, Lai CMS, Scheppach MW, Sia F, Ho KHK, Xiao X, Yip TCF, Lam TYT, Kwok HYH, Chan HCH, Lui RN, Chan TT, Wong MTL, Ho MF, Ko RCW, Hon SF, Chu S, Futaba K, Ng SSM, Yip HC, Tang RSY, Wong VWS, Chan FKL, Chiu PWY; ENDOAID-TRAIN study group. Effect of Real-Time Computer-Aided Polyp Detection System (ENDO-AID) on Adenoma Detection in Endoscopists-in-Training: A Randomized Trial. Clin Gastroenterol Hepatol. 2024 Mar;22(3):630-641.e4. doi: 10.1016/j.cgh.2023.10.019. Epub 2023 Nov 2.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Endoscopist wil not be blinded to treatment. Treatment arm allocation will be concealed to patients, data collector and data analysts.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident Specialist

Study Record Dates

First Submitted

March 23, 2021

First Posted

April 9, 2021

Study Start

April 19, 2021

Primary Completion

July 22, 2022

Study Completion

December 31, 2022

Last Updated

February 8, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

There is no plan to share individual participant data to other researchers

Locations